Prab at 13:00, 18 March 2025

2025-03-18T13:00:17Z

← Older revision		Revision as of 13:00, 18 March 2025
Line 20:		Line 20:
	[[Category:Blood cells]]		[[Category:Blood cells]]
	{{No image}}		{{No image}}
	~~__NOINDEX__~~

Prab: CSV import

2025-03-17T19:57:13Z

CSV import

← Older revision		Revision as of 19:57, 17 March 2025
Line 20:		Line 20:
	[[Category:Blood cells]]		[[Category:Blood cells]]
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T04:23:34Z

CSV import

← Older revision		Revision as of 04:23, 11 February 2025
Line 19:		Line 19:
	{{med stub}}		{{med stub}}
	[[Category:Blood cells]]		[[Category:Blood cells]]
			{{No image}}

Prab at 01:12, 28 September 2023

2023-09-28T01:12:01Z

New page

'''Neohemocytes''', colloquially known as "new blood cells", represent a significant advancement in the realm of medical biotechnology. Developed by researchers at the [[University of California at San Francisco (UCSF)]], these artificial red blood cells have the potential to revolutionize blood storage and transfusion practices.

=== Composition and Structure ===
Neohemocytes are not naturally occurring entities; rather, they are synthetically crafted to mimic some of the functionalities of authentic erythrocytes, or red blood cells. Their composition can be broken down as follows:
* Hemoglobin Molecules: These are naturally occurring proteins responsible for oxygen transport in real red blood cells. In neohemocytes, these molecules are artificially encapsulated<ref>Chang, T. M. (2005). Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery, 4(3), 221-235.</ref>.
* Fat Bubbles: These are primarily composed of phospholipids and cholesterol. By encasing hemoglobin within these bubbles, the neohemocyte structure is achieved.
* In terms of size, neohemocytes are considerably smaller than human erythrocytes, approximating one-twelfth the dimensions of the latter.

=== Advantages Over Natural Red Blood Cells ===
A compelling advantage of neohemocytes lies in their storage longevity. Traditional erythrocytes, when stored for transfusion purposes, have a shelf-life of approximately 35 days<ref>Hess, J. R. (2006). Red cell storage. Journal of Proteomics, 73(3), 368-373.</ref>. In stark contrast, neohemocytes boast a substantially prolonged storage time of roughly six months. This extended duration has the potential to mitigate challenges associated with blood shortages and storage logistics in medical facilities.

=== Potential for Oxygen-Carrying Content ===
While current iterations of neohemocytes utilize natural hemoglobin as the oxygen-carrying entity, future developments could potentially incorporate artificial hemoglobin. Though such a technique remains in its conceptual stage and is not yet commercially available, it paves the way for myriad advancements in the domain of artificial blood product research<ref>Winslow, R. M. (2008). Current status of oxygen carriers ("blood substitutes"): 2006. Vox Sanguinis, 94(2), 87-98.</ref>.

== Conclusion ==
The creation of neohemocytes underscores the progressive strides being made in medical biotechnology. As research continues to evolve, these artificial red blood cells may hold the key to addressing challenges associated with blood storage and transfusion. Further studies are crucial to ascertain their safety, efficacy, and broader applications in clinical settings.
== References ==
<references />
{{med stub}}
[[Category:Blood cells]]

Neohemocyte - Revision history

Prab at 13:00, 18 March 2025

Prab: CSV import

Prab: CSV import

Prab at 01:12, 28 September 2023